Strand Life Sciences has launched a genomics-powered liquid biopsy test, which will help in monitoring lung, breast, colorectal and other types of cancer.
Called Strand LB, the test helps in monitoring the presence, recurrence and response of cancer-related tumour.
The Strand LB technique provides sensitive detection of tumour traces with a simple drawing of blood. “The pain is minimal, invasiveness in addition to comprehensive tissue profile which is capable of detecting 1 molecule in 1000, and micro traces of the tumour,” said Vijay Chandru, an Indian Institute of Sciences (IISc) Professor and CMD, Strand Life Sciences.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.